Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development. - Wikidata - awgldk - TriplyDB

Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.

Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.

http://www.wikidata.org/entity/Q40255599

about

Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America Mosquito Exposure and Chikungunya and Dengue Infection among Travelers during the Chikungunya Outbreak in the Americas Dengue: knowledge gaps, unmet needs, and research priorities Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic review Zika virus-like particle (VLP) based vaccine Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil.Antibody-based assay discriminates Zika virus infection from other flaviviruses.Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis.Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding.Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study.Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia Baseline Characterization of Dengue Epidemiology in Yogyakarta City, Indonesia, before a Randomized Controlled Trial of for Arboviral Disease Control

P2860

Q27468903-0FBD231C-14D3-4979-B7AF-9ACBC07349F9 Q27468944-F941E91D-702C-4C7F-A637-8BBFFAAB4565 Q28581497-7388A36F-157F-468E-B5C0-A383CFE33997 Q28729764-AB536C5D-DE57-4337-A65C-50B1B3331D87 Q29353536-CA5A79B3-A695-42F6-AF09-2480A358EF87 Q30145640-2D9E65B6-B55B-4E07-80D4-A23FFA4E8D5D Q33723518-D0EA5533-716A-4945-A592-BC309AE8AD04 Q35856554-A615F97A-DDBD-4F9F-991B-F80AA1A48F83 Q37372595-1109BDD8-926A-4BFB-89F8-8C8C830E99D7 Q38157718-5C8EFD45-F147-467C-A39B-C51ADDF0CF53 Q38616705-793732B2-9A20-408B-9477-0AB90BF68EBB Q38734455-FEE04871-049D-4583-938B-F0806CD7D355 Q40045875-7FA25DC4-02CA-4226-A686-5FD4D9E91D33 Q40124689-7A180F98-2EA4-4FDD-9266-C78A98306951 Q41926510-1ADDE367-AE96-4398-83DD-1B2AD8850878 Q47553469-BCD87D54-1CFE-4B10-A59E-F6F5AA28E614 Q47555963-CF0FDD96-17C0-4E51-BFD4-F2182E742000 Q55046089-F37488E1-AF34-42A4-A2A1-A4A91891963E Q56476041-65140A9C-EFCC-485D-8C4D-F812321BA2AC Q59137507-053A9916-4CB4-4FC8-91D7-363CE596F60E

P2860

Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.

http://www.wikidata.org/entity/Q40255599

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Optimization and validation of ...... of dengue vaccine development.

@en

type

label

Optimization and validation of ...... of dengue vaccine development.

@en

prefLabel

Optimization and validation of ...... of dengue vaccine development.

@en

P1433

Q40255599-56A1498E-F192-49A5-884B-1D8F8D34BAA3

P1476

Q40255599-115E8268-C4EE-480F-B8A0-A303A9436DB0

P2093

Q40255599-1AE05B96-8C81-4C29-A0F4-8EC54331A2DC

Q40255599-35058ADC-B6A4-4018-8EE0-38F1BB712FD2

Q40255599-B7E856DD-C752-4703-8FE7-3D0BD9397364

Q40255599-C2EE91FB-A4B2-4528-A244-FD3EBB2ACC71

Q40255599-EDF94D06-F736-4AB4-8076-D344B4020882

Q40255599-EE92E3B6-02F3-4213-9D1E-9CA65599A557

P2860

Q40255599-03E45520-E47F-410F-B74A-1E991D0AAD86

Q40255599-0C2F08A3-031A-42D7-B491-31B1733E1E13

Q40255599-0F2BAD73-01BC-4579-AAB9-491C7A8FC105

Q40255599-12383558-830B-43CD-8F50-DA525F472357

Q40255599-1D967BF1-46DD-446E-932C-68C062DC18C7

Q40255599-25D71140-9FFD-4E0B-B338-BBAB4FB90C60

Q40255599-27E75E59-DE8B-4CC3-84B7-7EFCEC959E6E

Q40255599-30BF01F0-E83B-4661-90A8-8BAA7891F522

Q40255599-312F6E1A-7228-44D7-B5E1-90B38656F025

Q40255599-35750392-6528-41AB-B719-12867B269B3D

P304

Q40255599-2DCF1B62-1FDE-4015-A763-8FBEE0A5FA98

P31

Q40255599-65DB40CB-CF7F-48DC-92C4-FA956ECA7C96

P356

Q40255599-8CF48CB7-0FAB-4221-988C-9BD687DF42E2

P407

Q40255599-ED175F2E-2F34-47F4-9696-A6A7721339F5

P433

Q40255599-400FDCD4-EE97-4D5D-8BF6-0C86AA853C7B

P478

Q40255599-5DB6E78A-5799-4FA0-9A40-3D5CE952B40D

P577

Q40255599-EF22B0BB-8025-4767-A4D9-0207C26E57D1

P5875

Q40255599-A733291C-7569-4E9A-ACE3-CCE0046F4344

P698

Q40255599-3A6F93F4-6F1E-4DF7-935A-2C20E6877C95

P921

Q40255599-47AEF4A2-3B72-4BDA-B334-F3EA2DA02C27

P932

Q40255599-A7D6A923-BCBC-4967-967C-8566CB0CDCBF

P356

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Optimization and validation of ...... of dengue vaccine development.

@en

P2093

Branda T Hu

http://www.w3.org/2001/XMLSchema#string

Matthew I Bonaparte

http://www.w3.org/2001/XMLSchema#string

Ping Luo

http://www.w3.org/2001/XMLSchema#string

Rebecca Zedar

http://www.w3.org/2001/XMLSchema#string

Stephen W Hildreth

http://www.w3.org/2001/XMLSchema#string

Tatyana M Timiryasova

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of flaviviruses

Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

Discrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fc Receptor (Fc R)-Negative and Fc R-Expressing BHK-21 Cells

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

P304

962-970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.12-0461

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235786259

http://www.w3.org/2001/XMLSchema#string

P698

23458954

http://www.w3.org/2001/XMLSchema#string

P921

P932

3752766

http://www.w3.org/2001/XMLSchema#string